(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one (DAH-II) CAS: 156732-13-7
Catalog Number | XD93750 |
Product Name | (S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one (DAH-II) |
CAS | 156732-13-7 |
Molecular Formula | C32H32N2O |
Molecular Weight | 460.6093 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one, commonly known as DAH-II, is a compound with diverse applications in the field of medicinal chemistry. DAH-II belongs to the class of enones and has gained attention for its potential in the synthesis of various bioactive molecules.One significant application of DAH-II is its use as a key intermediate in the synthesis of novel pharmaceutical compounds. By incorporating DAH-II into the synthetic pathway, medicinal chemists can introduce different functional groups or modifications to generate compounds with potentially enhanced biological activities. These modifications can be crucial for optimizing potency, selectivity, and pharmacokinetic properties of the resulting molecules.DAH-II has shown promise in the development of potential anticancer agents. Research has demonstrated that derivatives of DAH-II possess cytotoxic activity against cancer cells. By modifying the structure of DAH-II, researchers can create compounds that selectively target cancer cells, inducing apoptosis or inhibiting specific cellular processes involved in tumor growth. This makes DAH-II a valuable tool in the discovery and development of novel anticancer drugs.Additionally, DAH-II derivatives have shown potential as antimicrobial agents. Research has indicated that certain modifications to the DAH-II structure can result in compounds with significant antibacterial, antifungal, and antiviral activities. These derivatives may offer alternative treatment options against drug-resistant pathogens and hold potential in combating various infectious diseases.Furthermore, DAH-II can serve as a precursor for the synthesis of enzyme inhibitors. By incorporating specific moieties into the DAH-II structure, researchers can design inhibitors that selectively target enzymes involved in disease mechanisms. These inhibitors may have applications in the treatment of conditions such as inflammation, neurodegenerative diseases, or cardiovascular disorders.Apart from its direct medicinal applications, DAH-II can also be used in the development of chemical probes for probing biological processes. Researchers can modify the structure of DAH-II to create fluorescent or labeled derivatives, which can help visualize and study specific cellular pathways or molecular interactions.In summary, (S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one (DAH-II) is a versatile compound with applications in medicinal chemistry. Its use as a key intermediate allows for the synthesis of novel pharmaceutical compounds with potentially enhanced biological activities. DAH-II derivatives show promise as anticancer and antimicrobial agents, as well as enzyme inhibitors. Furthermore, DAH-II can be utilized in the development of chemical probes for studying biological processes. Continued research and development of DAH-II and its derivatives can contribute to the discovery of new therapeutic options and advancements in the field of drug development.